Bio-Techne Corporation — Revenue by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d1d07354-3c7d-493b-b31a-cd22bea7fbb7/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2026 | $1.2B | 2025-07-01 – 2026-06-30 | evidence 0001104659-26-100322 |
| FY 2025 | $1.2B | 2024-07-01 – 2025-06-30 | evidence 0001558370-25-011716 |
| FY 2024 | $1.2B | 2023-07-01 – 2024-06-30 | evidence 0001558370-24-012430 |
| FY 2023 | $1.1B | 2022-07-01 – 2023-06-30 | evidence 0001558370-23-015226 |
| FY 2022 | $1.1B | 2021-07-01 – 2022-06-30 | evidence 0001558370-22-013935 |
| FY 2021 | $931.0M | 2020-07-01 – 2021-06-30 | evidence 0001437749-21-020980 |
| FY 2020 | $738.7M | 2019-07-01 – 2020-06-30 | evidence 0001437749-20-018754 |
| FY 2019 | $714.0M | 2018-07-01 – 2019-06-30 | evidence 0001437749-19-017565 |
| FY 2018 | $643.0M | 2017-07-01 – 2018-06-30 | evidence 0001437749-19-017565 |
| FY 2017 | $563.0M | 2016-07-01 – 2017-06-30 | evidence 0001437749-19-017565 |
| FY 2016 | $499.0M | 2015-07-01 – 2016-06-30 | evidence 0001437749-18-016190 |
| FY 2015 | $452.2M | 2014-07-01 – 2015-06-30 | evidence 0001437749-15-016645 |
| FY 2014 | $357.8M | 2013-07-01 – 2014-06-30 | evidence 0001193125-14-327566 |
| FY 2013 | $310.6M | 2012-07-01 – 2013-06-30 | evidence 0001193125-13-351961 |
| FY 2012 | $314.6M | 2011-07-01 – 2012-06-30 | evidence 0001193125-12-373084 |
| FY 2011 | $290.0M | 2010-07-01 – 2011-06-30 | evidence 0001193125-11-235045 |
| FY 2010 | $269.0M | 2009-07-01 – 2010-06-30 | evidence 0001193125-11-235045 |
| FY 2009 | $264.0M | 2008-07-01 – 2009-06-30 | evidence 0001193125-11-235045 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Bio-Techne Corporation — all facts · Net Income · Operating Income